Skip to main content
Subscribe
Register
Sign in
Membership
Insights
Events
About
Subscribe
Register
Sign in
Stephen Taub
Latest Articles
Premium
Citadel Added to Its 2022 Gains in September
Stephen Taub
October 7, 2022
Premium
Haidar Is Now Up 274 Percent
Stephen Taub
October 6, 2022
Premium
Bridgewater Continues to Kill It
Stephen Taub
October 5, 2022
Premium
Glenview Extends Losses in September
Stephen Taub
October 5, 2022
Premium
Hedge Funds Go Bottom Fishing in Biopharma
Stephen Taub
October 4, 2022
Premium
Greenlight Sidesteps September Swoon
Stephen Taub
October 3, 2022
Premium
Storm Clouds on the Horizon
Stephen Taub
September 30, 2022
Premium
Cadian Launches a New Fund
Stephen Taub
September 29, 2022
Premium
VC Investing Continues to Decline
Stephen Taub
September 28, 2022
Premium
Aurelius Capital’s Drawdown Funds Soar in 2022
Stephen Taub
September 27, 2022
Premium
Jana’s Latest Target
Stephen Taub
September 26, 2022
Premium
Oyo Valuation Cut Rocks Investors
Stephen Taub
September 23, 2022
Premium
Woodson Remains Committed to Peloton
Stephen Taub
September 22, 2022
Premium
Averill Suffers a Setback
Stephen Taub
September 21, 2022
Premium
Biopharma’s Healthy Private Market
Stephen Taub
September 20, 2022
Premium
D. E. Shaw’s Latest New Fund
Stephen Taub
September 19, 2022
Premium
Whale Rock Extends Losses
Stephen Taub
September 16, 2022
Premium
Life Sciences Funds Show Some Signs of Health
Stephen Taub
September 15, 2022
More Articles